Antigua and Barbuda vs Canada: Estimated antiretroviral therapy coverage among people living with HIV
Antigua and Barbuda
77.0%
in 2025
Canada
76.0%
in 2022
Antigua and Barbuda rank
64th
Canada rank
66th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Antigua and Barbuda
- Canada
How they compare
Antigua and Barbuda currently reports 77.0% against 76.0% in Canada, a difference of 1.0%.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 64th and Canada ranks 66th of 143 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.5% | 30.6% | 15.1% | Canada |
| 2010s | 43.8% | 64.0% | 20.2% | Canada |
| 2020s | 59.7% | 77.0% | 17.3% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Antigua and Barbuda or Canada?
- Antigua and Barbuda, at 77.0% against 76.0% in Canada as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Antigua and Barbuda and Canada?
- 1.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Canada?
- 23 years are reported by both, from 2000 to 2022.
- How do Antigua and Barbuda and Canada rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Antigua and Barbuda ranks 64th and Canada ranks 66th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.